Subcutaneous Fat Disorder Clinical Trial
Official title:
Cryolipolisis for Subcutaneous Abodomen and Flank Fat Reduction
Sixty healthy subjects aged between 18 and 50 will be randomly allocated into three treatment groups: Conventional Cryolipolysis, Contrast Cryolipolysis or Recovery Reperfusion Cryolipolysis. The region will be treated according to the individual need, in the region of abdomen and flanks. Assessments of body composition will be performed at baseline and 30, 60 and 90 days after randomization. Blood collections will also be performed at baseline and between 14 and 21 days after randomization for evaluation of lipid profile and liver function.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04090853 -
Subject Evaluation of a 1064nm Diode Laser/RF
|
N/A | |
Active, not recruiting |
NCT05760248 -
Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity
|
Phase 2 | |
Completed |
NCT05155683 -
Combination of Light and Ultrasound to Reduce Abdominal Fat
|
N/A |